Versor Investments LP Makes New Investment in Henry Schein, Inc. (NASDAQ:HSIC)

Versor Investments LP bought a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 5,446 shares of the company's stock, valued at approximately $377,000.

Several other large investors also recently bought and sold shares of the company. Proficio Capital Partners LLC acquired a new stake in Henry Schein in the fourth quarter valued at approximately $943,000. Oppenheimer Asset Management Inc. acquired a new stake in Henry Schein in the fourth quarter valued at approximately $904,000. K.J. Harrison & Partners Inc grew its position in Henry Schein by 61.1% in the fourth quarter. K.J. Harrison & Partners Inc now owns 29,000 shares of the company's stock valued at $1,988,000 after acquiring an additional 11,000 shares in the last quarter. Illinois Municipal Retirement Fund grew its position in Henry Schein by 35.3% in the fourth quarter. Illinois Municipal Retirement Fund now owns 122,352 shares of the company's stock valued at $8,467,000 after acquiring an additional 31,890 shares in the last quarter. Finally, Wealthspire Advisors LLC grew its position in Henry Schein by 5.9% in the fourth quarter. Wealthspire Advisors LLC now owns 15,772 shares of the company's stock valued at $1,091,000 after acquiring an additional 874 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Stock Performance

HSIC traded up $0.33 during trading hours on Thursday, hitting $71.79. 646,759 shares of the stock were exchanged, compared to its average volume of 1,476,320. The stock has a 50-day simple moving average of $74.44 and a 200-day simple moving average of $72.51. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.49. The stock has a market cap of $8.91 billion, a price-to-earnings ratio of 29.60, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter last year, the business earned $0.66 earnings per share. The business's revenue for the quarter was up 5.8% compared to the same quarter last year. Analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analyst Upgrades and Downgrades

HSIC has been the subject of several recent research reports. Jefferies Financial Group increased their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Mizuho assumed coverage on Henry Schein in a research note on Wednesday, December 4th. They set a "neutral" rating and a $75.00 target price for the company. UBS Group reduced their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research note on Wednesday, February 26th. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and increased their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Finally, Barrington Research reiterated an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Henry Schein currently has an average rating of "Moderate Buy" and a consensus target price of $81.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.